tramadol has been researched along with Glioblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corona-Ramos, JN; Déciga-Campos, M; García-López, P; Jaramillo-Morales, OA; López-Muñoz, FJ; Martínez-Racine, I; Medina, LA; Romero-Piña, M | 1 |
| Huang, H; Ma, L; Peng, J; Peng, Y; Shao, M; Wang, L; Xia, Z; Zhong, G; Zhu, Z | 1 |
2 other study(ies) available for tramadol and Glioblastoma
| Article | Year |
|---|---|
The Effect of Gabapentin and Tramadol in Cancer Pain Induced by Glioma Cell in Rat Femur.
Topics: Amines; Analgesics; Animals; Bone Neoplasms; Brain Neoplasms; Cancer Pain; Cell Line, Tumor; Cell Survival; Cyclohexanecarboxylic Acids; Femur; Gabapentin; gamma-Aminobutyric Acid; Glioblastoma; Hyperalgesia; Neoplasm Transplantation; Pain Measurement; Rats; Tramadol; Treatment Outcome | 2017 |
Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43‑mediated gap junction intercellular communication.
Topics: Analgesics, Opioid; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Communication; Cell Line, Tumor; Connexin 43; Dacarbazine; Drug Interactions; Gap Junctions; Glioblastoma; Humans; Temozolomide; Tramadol; Transfection | 2018 |